Catalent New Product Introduction Process
Catalent, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, employs an active New Product Introduction (NPI) programme, which has seen the global introduction of nearly a hundred new consumer health and Rx products in the last year.
Catalent New Product Introduction Process
Catalent, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, employs an active New Product Introduction (NPI) programme, which has seen the global introduction of nearly a hundred new consumer health and Rx products in the last year. Catalent has an active NPI pipeline of several hundred products and the number of NPIs completed has grown significantly year-on-year.
Catalent employs rigorous systems to drive and deliver robust, “right first time” development and technical transfer into reliable manufacture and supply.
www.catalent.com[email protected]
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
